Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could lower gas pressure during robotic Weight-Loss surgery mean less pain and faster recovery?

NCT ID NCT07710352

Symptom relief Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Aug 21, 2026 · Updated 2 times

Summary

This trial compares using a lower gas pressure (8 mmHg) with the AirSeal device versus standard pressure (15 mmHg) during robotic weight-loss surgery. The goal is to see if lower pressure helps patients feel less pain and leave the recovery room sooner. Adults aged 18 and older having robotic sleeve gastrectomy or gastric bypass are eligible.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AirSeal Robotic Solution device used for low-pressure (8 mmHg) carbon dioxide insufflation during robotic bariatric surgery
What this could lead to
If it works, this could lead to less pain and faster recovery after robotic weight-loss surgery, potentially shortening hospital stays.
What could go wrong
This is a single-center trial with 100 participants, so results may not apply to all patients or hospitals. Lower pressure might not provide adequate surgical visibility or safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older * Scheduled to undergo robotic-assisted surgery at New York-Presbyterian/Weill Cornell Medical Center * American Society of Anesthesiologists physical status I-III * Able to understand and provide written informed consent in English Exclusion Criteria: * American Society of Anesthesiologists physical status IV or higher (i.e. a severe systemic disease that is a constant threat to life such as decompensated heart failure) * Chronic opioid use (≥30 morphine milligram equivalents per day for ≥30 days within the past 6 months) * Current pregnancy * Inability to understand and provide informed consent in English * Inability to provide informed consent due to cognitive impairment or other conditions impacting decision-making capacity * Scheduled open or laparoscopic surgeries

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity / overweight are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder Pain Pneumoperitoneum

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity / overweight Pneumoperitoneum Robotic surgery

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • New York-Presbyterian/Weill Cornell Medical Center GI Metabolic and Bariatric Surgery

    RECRUITING

    New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.